Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-system Disease Diagnosis”

5,134 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,134 results

Not applicableUnknownNCT05797402
What this trial is testing

Clinical and Biological Sample Database of Chinese Elderly Patients With Multiple Diseases

Who this might be right for
Comorbidities and Coexisting ConditionsOld Age; Debility
Beijing Anzhen Hospital 10,000,000
Early research (Phase 1)Looking for participantsNCT06809400
What this trial is testing

LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Who this might be right for
Parkinson Disease
Eli Lilly and Company 127
Testing effectiveness (Phase 2)Study completedNCT01599637
What this trial is testing

Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment

Who this might be right for
Chronic Idiopathic Urticaria
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Ended earlyNCT01416181
What this trial is testing

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Biogen 889
Testing effectiveness (Phase 2)Ended earlyNCT01555281
What this trial is testing

Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Swiss Cancer Institute 33
Not applicableLooking for participantsNCT06658730
What this trial is testing

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

Who this might be right for
Vascular DiseaseDissectionDissection Aortic Aneurysm+5 more
W.L.Gore & Associates 1,500
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Large-scale testing (Phase 3)Ended earlyNCT01097330
What this trial is testing

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia

Who this might be right for
Defibrillators, ImplantableTachycardia, Ventricular
Population Health Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT01246557
What this trial is testing

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Who this might be right for
Chronic Lymphatic Leukemia
Hospital Universitari Vall d'Hebron Research Institute 20
Not applicableUnknownNCT03424772
What this trial is testing

Whole Genome Sequencing in the Detection of Rare Undiagnosed Genetic Diseases in Children in China

Who this might be right for
Intellectual DisabilityMultiple Congenital AnomalyRare Diseases
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Large-scale testing (Phase 3)Study completedNCT05425719
What this trial is testing

Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

Who this might be right for
Chronic Kidney Disease
MediBeacon 249
Testing effectiveness (Phase 2)Study completedNCT01279577
What this trial is testing

Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease

Who this might be right for
Crohn´s Disease
Dr. Falk Pharma GmbH 254
Testing effectiveness (Phase 2)Ended earlyNCT01699581
What this trial is testing

Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant

Who this might be right for
Hodgkin's LymphomaMultiple MyelomaNon-Hodgkin's Lymphoma
Greg Monohan 35
Early research (Phase 1)Ended earlyNCT01028209
What this trial is testing

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Who this might be right for
Alzheimer DiseaseParkinson DiseaseMultiple Sclerosis
Institute for Neurodegenerative Disorders 12
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT04131504
What this trial is testing

Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)

Who this might be right for
Crohn's DiseaseIBD
Children's Hospital Medical Center, Cincinnati 239
Very early researchStudy completedNCT05357833
What this trial is testing

Novel Imaging Markers in SPMS

Who this might be right for
Secondary Progressive Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis
University of Utah 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06431971
What this trial is testing

Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease

Who this might be right for
Parkinson Disease
InnoMedica Schweiz AG 40
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Testing effectiveness (Phase 2)Looking for participantsNCT07106736
What this trial is testing

MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China 60
Load More Results